EDUCATE PATIENTS ABOUT THE VOLUNTARY FORTEO PATIENT REGISTRY AND ENCOURAGE THEM TO ENROLL

The FORTEO Patient Registry plays an important role in monitoring the long-term safety of FORTEO, including the potential risk of osteosarcoma

Patient participation is voluntary and involves the following 3 steps:

Patient completes the brief information on the pre-enrollment card.

After the pre-enrollment card is received, the patient will be mailed a one-page informed consent form, a short registration form, and a $5 token of appreciation for the patient's time in completing the forms.*

Patient returns the informed consent and registration forms to the voluntary FORTEO Patient Registry.

That's it. Once the patient has returned the consent and registration forms, the patient will not be contacted further without his/her consent.

Patients can pre-enroll in the voluntary FORTEO Patient Registry by completing a form found within any of the following:

  • Their FORTEO prescription
  • Their FORTEO Patient Starter Kit
  • The voluntary FORTEO Patient Registry Brochure

Or by:

*We want you to know that RTI International, a non-profit research company, is conducting this safety study on behalf of Eli Lilly and Company, the makers of FORTEO. Your patient's personal information, including any data that can identify patients, will not be shared with Eli Lilly and Company or anyone outside the research team without the patient's permission.

SAFETY INFORMATION AND BOXED WARNING

expand